Clovis Oncology, Inc. Uncategorized Contracts & Agreements

45 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Superpriority Debtor-In-Possession Facility Commitment Letter, dated as of December 11, 2022, by and among Clovis Oncology, Inc. and the Commitment Parties
Clovis Oncology, Inc.
Biotechnology
NY
2022
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Clovis Oncology, Inc.
Biotechnology
2020
CLOVIS ONCOLOGY, INC.
Clovis Oncology, Inc.
Biotechnology
2015
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments
Clovis Oncology, Inc.
Biotechnology
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments
Clovis Oncology, Inc.
Biotechnology
CO
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments
Clovis Oncology, Inc.
Biotechnology
DE
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments
Clovis Oncology, Inc.
Biotechnology
AZ
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments
Clovis Oncology, Inc.
Biotechnology
DE
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments
Clovis Oncology, Inc.
Biotechnology
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments
Clovis Oncology, Inc.
Biotechnology
CO
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments
Clovis Oncology, Inc.
Biotechnology
NY
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments
Clovis Oncology, Inc.
Biotechnology
NY
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments
Clovis Oncology, Inc.
Biotechnology
NY
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments
Clovis Oncology, Inc.
Biotechnology
CO
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments
Clovis Oncology, Inc.
Biotechnology
CO
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments
Clovis Oncology, Inc.
Biotechnology
CO
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments
Clovis Oncology, Inc.
Biotechnology
CO
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments
Clovis Oncology, Inc.
Biotechnology
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments. Many of...
Clovis Oncology, Inc.
Biotechnology
AZ
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments. Many of...
Clovis Oncology, Inc.
Biotechnology
DE
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments. Many of...
Clovis Oncology, Inc.
Biotechnology
CO
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments. Many of...
Clovis Oncology, Inc.
Biotechnology
CO
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments. Many of...
Clovis Oncology, Inc.
Biotechnology
CO
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments. Many of...
Clovis Oncology, Inc.
Biotechnology
CO
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments. Many of...
Clovis Oncology, Inc.
Biotechnology
DE
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments. Many of...
Clovis Oncology, Inc.
Biotechnology
DE
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments. Many of...
Clovis Oncology, Inc.
Biotechnology
DE
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments. Many of...
Clovis Oncology, Inc.
Biotechnology
DE
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments. Many of...
Clovis Oncology, Inc.
Biotechnology
DE
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments. Many of...
Clovis Oncology, Inc.
Biotechnology
DE
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments. Many of...
Clovis Oncology, Inc.
Biotechnology
DE
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments. Many of...
Clovis Oncology, Inc.
Biotechnology
DE
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments. Many of...
Clovis Oncology, Inc.
Biotechnology
DE
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments. Many of...
Clovis Oncology, Inc.
Biotechnology
DE
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments. Many of...
Clovis Oncology, Inc.
Biotechnology
DE
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments. Many of...
Clovis Oncology, Inc.
Biotechnology
CO
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments. Many of...
Clovis Oncology, Inc.
Biotechnology
CO
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments. Many of...
Clovis Oncology, Inc.
Biotechnology
CO
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments. Many of...
Clovis Oncology, Inc.
Biotechnology
CO
2011
Focus on oncology. The oncology market is characterized by a number of disorders with high rates of recurrence and a limited response from current therapies or treatments. Many of...
Clovis Oncology, Inc.
Biotechnology
CO
2011